2nd Circ. Backs Dismissal of Bristol-Myers Clinical Trial Suit
The Second Circuit on Friday agreed with a New York federal court that investors hadn't shown that Bristol-Myers hid information about patients in a clinical trial for a new lung cancer...To view the full article, register now.
Already a subscriber? Click here to view full article